Ovarian Cancer Heroes Come in Many Forms

Even after surgery and chemotherapy, I make sure to shine through cancer and any fear that stares at me.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

My genetic testing covered 648 gene variants. Of course, researchers only know the significance of a fraction of those variants.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

After my treatment ended for triple-negative breast cancer, I thought I was done with cancer — and then I was diagnosed with ovarian cancer.

A novel antibody drug conjugate was granted a Fast Track designation for certain patients with ovarian cancer.